Telephone: 212.931.0704

Mylan Pharmaceuticals, Inc., et. al. v. Warner Chilcott Public Limited Co.,, 2:12-cv-02824-PD (E.D. Pa.)

We represented plaintiffs and direct purchasers of Doryx in this class action alleging that the maker and seller of Doryx engaged in an anticompetitive scheme to illegally extend their monopoly in the market for delayed-release doxycycline hyclate in violation of the federal antitrust laws.  We were involved in all aspects of the litigation, which ultimately led to a $15 million settlement for the class of direct purchasers.

Reach Out

Taus, Cebulash & Landau, LLP • 80 Maiden Lane • Suite 1204 • New York, NY 10038 • T: 212.931.0704 • E: